Virbac (LTS:0NM7) FFO


LTS:0NM7 Virbac SA LTS:0NM7
91 GF Score
Price €322.50
GF Value €364.75
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Virbac FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0NM7
91GF Score
Virbac SA LTS:0NM7
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Virbac (LTS:0NM7) Overvalued in 2026?

Based on GuruFocus' analysis, Virbac stock appears to be undervalued. The current stock price of €322.50 is trading 11.6% below its estimated GF Value™ of €364.75. GuruFocus considers Virbac to be Modestly Undervalued.

Key valuation signals for LTS:0NM7:

  • FFO:
  • GF Value™: €364.75 vs. price of €322.50 (11.6% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the LTS:0NM7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Virbac Business Description

Address 13e rue, 1ere avenue 2065, LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
91GF Score

Get the complete analysis for LTS:0NM7

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€322.50
Price
€364.75
GF Value